Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,282 public trials 1,199 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

NCT07327489

Conditions
Advanced Solid Tumors Cancer, Bladder Cancer, Breast Diseases, +64 more
Locations
  • Mercy Hospital - FTS Fort Smith, Arkansas, United States
  • Frederick Health Hospital Frederick, Maryland, United States
  • Mercy Hospital - SPG Springfield, Missouri, United States
  • Mercy Hospital - South St Louis, Missouri, United States
View Trial Details
Recruiting

GCC 2546- Motion Management

NCT07398209

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

NCT06914128

Conditions
Astrocytoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • UCLA Health Bowyer Oncology Center Los Angeles, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights - Neurology San Francisco, California, United States
View all 60 locations
View Trial Details
Recruiting

Gilteritinib for the Treatment of ALK NSCLC

NCT06225427

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Recruiting

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

NCT06598306

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Cancer, +8 more
Locations
  • University of Southern California, Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • Trinity Health Saint Joseph Mercy Ann Arbor Ann Arbor, Michigan, United States
  • Avera Cancer Institute Sioux Falls, South Dakota, United States
View all 31 locations
View Trial Details
Recruiting

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

NCT04614103

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Banner Health MD Anderson Gilbert, Arizona, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 71 locations
View Trial Details
Recruiting

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

NCT06216301

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Western Regional Medical Center, LLC Goodyear, Arizona, United States
  • St. Jude Herritage Medical Group Fullerton, California, United States
  • Hoag Family Cancer Institute - Hoag Memorial Hospital Newport Beach, California, United States
View all 98 locations
View Trial Details

Related conditions